Varanasi: A team of skilled doctors at the Cardiology department at the Institute of Medical Sciences (IMS), Banaras Hindu ...

An experimental drug originally developed by Sanofi that is now being advanced by the Mayo Clinic significantly curbed ...

Journi Kelly, 11, needed a new heart. But her heart valves helped 2 other girls and allowed doctors to perform the 1st living ...

Fibrosis predicts post-surgical risk in aortic stenosis, reinforcing its role in guiding treatment decisions for both sexes.

Medtronic, a leader in medical technology and Philips, a leader in health technology announced the signing of a Memorandum of ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

A new study has found that one in five older adults develops an infection within six months after heart surgery, with women ...

The Health Insurance Corp. (PhilHealth) has increased its coverage for open heart surgeries to almost P1 million and launched ...

Serious heart problems kept one local senior from dancing with his wife. But thanks to a life-saving procedure at White ...

An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...

Previous observational studies have highlighted the advantages of mechanical valves over tissue valves for middle-aged ...

Sanofi's experimental drug ataciguat has shown promise in reducing the progression of aortic valve stenosis in clinical trials, potentially delaying the need for surgical valve replacement. With ...